LY 334370 (BioDeep_00000794672)
代谢物信息卡片
化学式: C21H22FN3O (351.1747)
中文名称: LY 334370盐酸盐
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)NC(=O)C4=CC=C(C=C4)F
InChI: InChI=1S/C21H22FN3O/c1-25-10-8-14(9-11-25)19-13-23-20-7-6-17(12-18(19)20)24-21(26)15-2-4-16(22)5-3-15/h2-7,12-14,23H,8-11H2,1H3,(H,24,26)
描述信息
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
LY334370 is a selective 5-HT1F receptor agonist with a Ki of 1.6 nM.
同义名列表
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Sara M Garrett, Ryan M Whitaker, Craig C Beeson, Rick G Schnellmann. Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.
The Journal of pharmacology and experimental therapeutics.
2014 Aug; 350(2):257-64. doi:
10.1124/jpet.114.214700. [PMID: 24849926] - David L Nelson, Lee A Phebus, Kirk W Johnson, David B Wainscott, Marlene L Cohen, David O Calligaro, Yao-Chang Xu. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
Cephalalgia : an international journal of headache.
2010 Oct; 30(10):1159-69. doi:
10.1177/0333102410370873. [PMID: 20855361] - David B Wainscott, Joseph H Krushinski, James E Audia, John M Schaus, John M Zgombick, Virginia L Lucaites, David L Nelson. [3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
Naunyn-Schmiedeberg's archives of pharmacology.
2005 Mar; 371(3):169-77. doi:
10.1007/s00210-005-1035-9. [PMID: 15900510] - Sandra A Filla, Brian M Mathes, Kirk W Johnson, Lee A Phebus, Marlene L Cohen, David L Nelson, John M Zgombick, Jon A Erickson, Kathryn W Schenck, David B Wainscott, Theresa A Branchek, John M Schaus. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
Journal of medicinal chemistry.
2003 Jul; 46(14):3060-71. doi:
10.1021/jm030020m. [PMID: 12825944] - D J Williamson, R G Hill, S L Shepheard, R J Hargreaves. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
British journal of pharmacology.
2001 Aug; 133(7):1029-34. doi:
10.1038/sj.bjp.0704162. [PMID: 11487512] - S Shepheard, L Edvinsson, M Cumberbatch, D Williamson, G Mason, J Webb, S Boyce, R Hill, R Hargreaves. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
Cephalalgia : an international journal of headache.
1999 Dec; 19(10):851-8. doi:
10.1046/j.1468-2982.1999.1910851.x. [PMID: 10668103]
